BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
4.300
-0.210 (-4.66%)
Apr 28, 2026, 4:00 PM EDT - Market closed
BioAtla Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 7 | 34 | 34 | 118 | 881 | 2,158 | |
| Market Cap Growth | -58.62% | -2.30% | -70.91% | -86.61% | -59.20% | -40.57% | |
| Enterprise Value | 6 | 31 | -21 | -21 | 707 | 1,888 | |
| Last Close Price | 4.30 | 28.39 | 29.56 | 123.00 | 412.50 | 981.50 | |
| PS Ratio | 3.56 | 16.76 | 3.12 | - | - | 8633.02 | |
| PB Ratio | - | -0.93 | 2.40 | 1.67 | 4.88 | 10.24 | |
| P/TBV Ratio | - | - | 2.40 | 1.67 | 4.88 | 10.24 | |
| EV/Sales Ratio | 3.10 | 15.69 | - | - | - | 7553.32 | |
| Debt / Equity Ratio | -0.17 | -0.17 | 0.06 | 0.04 | 0.02 | 0.03 | |
| Net Debt / Equity Ratio | 0.03 | 0.03 | -3.38 | -1.54 | -1.17 | -1.14 | |
| Net Debt / EBITDA Ratio | 0.02 | 0.02 | 0.66 | 0.85 | 1.98 | 2.52 | |
| Net Debt / FCF Ratio | 0.02 | 0.02 | 0.67 | 1.05 | 2.33 | 3.80 | |
| Asset Turnover | 0.06 | 0.06 | 0.13 | - | - | 0.00 | |
| Quick Ratio | 0.33 | 0.33 | 3.37 | 3.93 | 9.32 | 12.37 | |
| Current Ratio | 0.37 | 0.37 | 3.52 | 4.11 | 9.53 | 12.48 | |
| Return on Equity (ROE) | - | - | -164.30% | -98.37% | -54.44% | -45.34% | |
| Return on Assets (ROA) | -110.76% | -110.76% | -53.71% | -46.93% | -28.15% | -24.14% | |
| Return on Capital Employed (ROCE) | 725.30% | 725.30% | -195.20% | -142.00% | -53.40% | -41.10% | |
| Earnings Yield | -836.62% | -177.86% | -203.40% | -104.70% | -12.09% | -4.42% | |
| FCF Yield | -676.57% | -143.83% | -209.70% | -88.29% | -10.30% | -2.93% | |
| Buyback Yield / Dilution | -21.11% | -21.11% | -1.67% | -22.73% | -12.63% | -310.07% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.